DHR Potential Buy setupReasons for bullish bias:
- Price bounced from support
- Entry is at breakout of HH
- DOW theory, SL at last HL
Entry Level (CMP): 244.95
Stop Loss Level: 222.23
Take Profit Level 1: 267.67
Take Profit Level 2: 290.39
0.01BRL
23.80 BBRL
119.33 BBRL
About DANAHER CORPDRN
Sector
Industry
CEO
Rainer M. Blair
Website
Headquarters
Washington
Employees (FY)
63 K
Founded
1984
ISIN
BRDHERBDR004
FIGI
BBG008P6N1G6
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
DHR - ATH again soonLeaders lead. Has delivered incredible value to shareholders over the last decade. No reason to doubt why it couldn't continue.
Break out of this the daily range should push it to 270 soon.
Disclaimer: no position yet.
Danaher Corp. | Buy Scenario | Wine and waterDanaher in an interesting spot. We are under a resistance level (Resistance area 1) however the level was engulfed already (see orange marking). Looking to buy into if the following should develop:
1. Price breaks above Buy area 1 i want to see a close and open of a weekly or daily candle atleast.
DHR Sell off Misunderstood.The recent DHR Sell off is Misunderstood IMO.
Thoughts where that the recent weight loss drugs innovation will negate the need for life or medical device support for these patient types.
And while this is true in the short term, it does not negate the requirements - unless a complete reversal of the
DHR, Massive BULLISH Wedge-Formation, Major BREAKOUT Incoming!Hello There!
Welcome to my new analysis of DHR. The stock market is in a really important condition currently as there are many interesting stock gems within the market I have spotted in my analytics backend. One of the interesting gems I recently spotted for a major opportunity on the long side o
Danaher (DHR): Life Sciences GiantA Great Business | Fund Favorite | Danaher is a stock Mutual and Hedge Funds Love | The company has a stellar high-moat M&A-driven business model with strong pricing power and often anti-cyclical customers | Compounder Starts To Look Attractive
Dividend Stock Brilliance | Danaher has a wide-moat bu
watching DHR for a potential short-term bullish trade"Based on 17 Wall Street analysts offering 12 month price targets for Danaher in the last 3 months. The average price target is $277.76 with a high forecast of $310.00 and a low forecast of $250.00. The average price target represents a 19.37% change from the last price of $232.69."
- Tipranks
DHR with a bearish outlook following its earnings #StocksThe PEAD projected a bearish outlook for DHR after a negative under reaction following its earnings release placing the stock in drift D with an expected accuracy of 40%.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where DHER34 is featured.
